Telesis Bio Price History

TBIODelisted Stock  USD 2.98  0.02  0.67%   
If you're considering investing in Telesis Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Telesis Bio stands at 2.98, as last reported on the 27th of November, with the highest price reaching 3.15 and the lowest price hitting 2.82 during the day. Telesis Bio is out of control given 3 months investment horizon. Telesis Bio owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.1, which indicates the firm had a 0.1% return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 3.2% are justified by taking the suggested risk. Use Telesis Bio Coefficient Of Variation of 1535.52, risk adjusted performance of 0.0594, and Semi Deviation of 12.47 to evaluate company specific risk that cannot be diversified away.
  
Telesis Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1035

Best PortfolioBest Equity
Good ReturnsTBIO
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 30.89
  actual daily
96
96% of assets are less volatile

Expected Return

 3.2
  actual daily
63
63% of assets have lower returns

Risk-Adjusted Return

 0.1
  actual daily
8
92% of assets perform better
Based on monthly moving average Telesis Bio is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Telesis Bio by adding it to a well-diversified portfolio.

Telesis Bio Pink Sheet Price History Chart

There are several ways to analyze Telesis Stock price data. The simplest method is using a basic Telesis candlestick price chart, which shows Telesis Bio price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Telesis Pink Sheet Price History Data

The price series of Telesis Bio for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 4.14 with a coefficient of variation of 21.77. The price distribution for the period has arithmetic mean of 3.51. The median price for the last 90 days is 3.67. The company completed stock split (1:18) on 9th of May 2024.
OpenHighLowCloseVolume
11/27/2024
 3.00  3.15  2.82  2.98 
10/03/2024 3.00  3.15  2.82  2.98  77,270 
10/02/2024 3.12  3.20  3.00  3.17  73,367 
10/01/2024 3.61  3.75  3.15  3.35  224,100 
09/30/2024 2.90  3.95  2.60  3.83  628,475 
09/27/2024 3.21  3.62  2.86  3.23  1,880,542 
09/26/2024 4.86  5.08  3.12  3.99  25,853,599 
09/25/2024 2.75  2.75  2.18  2.32  3,138,442 
09/24/2024 3.56  3.56  2.71  2.71  196,338 
09/23/2024 2.99  3.82  2.96  3.57  600,257 
09/20/2024 2.96  3.18  2.61  3.09  695,785 
09/19/2024 4.13  5.17  2.34  2.93  53,708,089 
09/18/2024 1.43  1.45  1.33  1.36  833,261 
09/17/2024 1.55  1.62  1.27  1.40  116,121 
09/16/2024 1.55  1.68  1.48  1.55  45,904 
09/13/2024 1.55  1.74  1.55  1.60  239,758 
09/12/2024 1.65  2.05  1.63  1.81  476,187 
09/11/2024 1.65  1.70  1.45  1.70  245,627 
09/10/2024 3.81  3.98  3.78  3.80  59,058 
09/09/2024 3.96  4.08  3.81  3.93  15,485 
09/06/2024 4.18  4.18  3.76  3.83  13,293 
09/05/2024 3.62  4.07  3.58  4.07  37,315 
09/04/2024 3.46  3.65  3.38  3.55  38,795 
09/03/2024 3.47  3.60  3.35  3.42  79,912 
08/30/2024 3.43  3.56  3.36  3.42  40,704 
08/29/2024 3.35  3.50  3.35  3.36  6,850 
08/28/2024 3.56  3.56  3.37  3.38  3,187 
08/27/2024 3.52  3.57  3.34  3.43  9,363 
08/26/2024 3.57  3.70  3.37  3.40  24,829 
08/23/2024 3.69  3.74  3.44  3.44  50,718 
08/22/2024 3.73  3.73  3.63  3.70  6,260 
08/21/2024 3.57  3.74  3.43  3.63  11,379 
08/20/2024 3.54  3.73  3.43  3.45  13,585 
08/19/2024 3.62  3.68  3.56  3.56  73,741 
08/16/2024 3.56  3.71  3.44  3.68  52,213 
08/15/2024 3.71  3.91  3.56  3.62  20,469 
08/14/2024 3.40  3.73  3.36  3.54  36,010 
08/13/2024 3.45  3.60  3.35  3.45  57,722 
08/12/2024 3.58  3.70  3.31  3.31  37,834 
08/09/2024 3.87  4.23  3.61  3.67  75,352 
08/08/2024 4.20  4.59  3.61  3.64  120,187 
08/07/2024 4.29  4.64  4.03  4.25  70,665 
08/06/2024 4.29  4.85  4.16  4.40  80,100 
08/05/2024 5.00  5.45  4.17  4.17  255,761 
08/02/2024 5.31  6.17  3.67  5.50  2,946,093 
08/01/2024 3.52  4.40  3.37  4.22  242,553 
07/31/2024 3.78  6.06  3.46  3.92  1,772,920 
07/30/2024 4.20  4.20  3.95  3.95  28,290 
07/29/2024 4.00  4.23  3.93  4.21  22,206 
07/26/2024 4.07  4.10  3.98  4.10  3,774 
07/25/2024 4.05  4.08  3.91  3.92  2,754 
07/24/2024 3.69  4.15  3.69  4.10  11,932 
07/23/2024 4.13  4.25  3.85  4.10  7,844 
07/22/2024 4.18  4.20  3.84  4.12  20,660 
07/19/2024 4.07  4.16  3.90  4.00  11,593 
07/18/2024 4.17  4.36  3.94  4.18  41,930 
07/17/2024 3.64  4.10  3.62  3.89  21,122 
07/16/2024 3.30  3.85  3.30  3.85  48,037 
07/15/2024 3.60  4.00  3.33  3.36  105,390 
07/12/2024 3.51  3.69  3.50  3.67  27,918 
07/11/2024 3.70  3.92  3.50  3.70  611,459 

About Telesis Bio Pink Sheet history

Telesis Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Telesis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Telesis Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Telesis Bio stock prices may prove useful in developing a viable investing in Telesis Bio
Translate Bio, Inc., a clinical-stage messenger RNA therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company was founded in 2011 and is headquartered in Lexington, Massachusetts. Translate Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.

Telesis Bio Pink Sheet Technical Analysis

Telesis Bio technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Telesis Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Telesis Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Sectors Now

   

Sectors

List of equity sectors categorizing publicly traded companies based on their primary business activities
All  Next Launch Module

Telesis Bio Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Telesis Bio's price direction in advance. Along with the technical and fundamental analysis of Telesis Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Telesis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in Telesis Pink Sheet

If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation